Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-3.49	-4.97	-3.73	-1.34	-3.38
Depreciation & Amortization	0.09	0.07	0.08	0	0.02
Share-Based Compensation	1.81	1.38	0.23	0.31	0.01
Other Operating Activities	-0.15	2.04	1.82	-0.85	2.55
Operating Cash Flow	-1.75	-1.48	-1.59	-1.88	-0.81
Capital Expenditures	0	-0.03	-0.01	-0	0
Investing Cash Flow	0	-0.03	-0.01	-0	0
Common Stock Issued	0.44	3.72	2.1	1.74	0.64
Share Repurchases	0	0	-0.13	0	0
Other Financing Activities	-0.41	-0.54	-0.16	-0.58	1.07
Financing Cash Flow	0.02	3.18	2.07	1.16	1.71
Net Cash Flow	-1.72	1.67	0.46	-0.72	0.9
Free Cash Flow	-1.75	-1.51	-1.61	-1.88	-0.81
Free Cash Flow Margin	-1781.63%	-11607.69%	-1982.72%	-1839.22%	-2238.89%
Free Cash Flow Per Share	-0.03	-0.05	-0.12	-0.17	-0.24

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.